Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 1, 2007, Pages

  Bonde, Pramod ^a   Gao, Daqing ^a   Chen, Lei ^a   Duncan, Mark ^a   Miyashita, Tomoharu ^a   Montgomery, Elizabeth ^a   Harmon, John W ^a   Wei, Chiming ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; 8 OXOGUANINE GLYCOSYLASE; CASPASE; DNA BASE; DNA GLYCOSYLTRANSFERASE; N METHYL N PENTYLNITROSAMINE; NITROSAMINE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DNA REPAIR; DUODENOGASTRIC REFLUX; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; EXCISION REPAIR; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; RAT; SQUAMOUS CELL CARCINOMA; UPREGULATION; WESTERN BLOTTING;

EID: 33845761010     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.06.050     Document Type: Article

References (30)

1. Blot W.J., Devesa S.S., Kneller R.W., and Fraumeni Jr. J.F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265 (1991) 1287-1289
2. Pohl H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
3. Lagergren J., Bergstrom R., Lindgren A., and Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
4. Green J.A., Amaro R., and Barkin J.S. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. Dig Dis Sci 45 (2000) 2367-2368
5. Attwood S.E., Smyrk T.C., DeMeester T.R., Mirvish S.S., Stein H.J., and Hinder R.A. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 111 (1992) 503-510
6. Miwa K., Sahara H., Segawa M., et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67 (1996) 269-274
7. Sato T., Miwa K., Sahara H., Segawa M., and Hattori T. The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens. Anticancer Res 22 (2002) 39-44
8. Farhadi A., Fields J., Banan A., and Keshavarzian A. Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer?. Am J Gastroenterol 97 (2002) 22-26
9. Liu L., Ergun G., Ertan A., Woods K., Sachs I., and Younes M. Detection of oxidative DNA damage in oesophageal biopsies of patients with reflux symptoms and normal pH monitoring. Aliment Pharmacol Ther 18 (2003) 693-698
10. Sihvo E.I., Salminen J.T., Rantanen T.K., et al. Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int J Cancer 102 (2002) 551-555
11. Ames B.N., and Gold L.S. Endogenous mutagens and the causes of aging and cancer. Mutat Res 250 (1991) 3-16
12. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., and Loeb L.A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions. J Biol Chem 267 (1992) 166-172
13. Moriya M., and Grollman A.P. Mutations in the mutY gene of Escherichia coli enhance the frequency of targeted G:C→T:A transversions induced by a single 8-oxoguanine residue in single-stranded DNA. Mol Gen Genet 239 (1993) 72-76
14. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 1513-1530
15. Xing D.Y., Tan W., Song N., and Lin D.X. Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 95 (2001) 140-143
16. Belzile J.P., Choudhury S.A., Cournoyer D., and Chow T.Y. Targeting DNA repair proteins: a promising avenue for cancer gene therapy. Curr Gene Ther 6 (2006) 111-123
17. Madhusudan S., and Middleton M.R. The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer. Cancer Treat Rev 31 (2005) 603-617
18. Lin H., Roseborough G., Dong Y., Williams G.M., and Wei C. DNA damage and repair system in spinal cord ischemia. J Vasc Surg 37 (2003) 847-858
19. Wetscher G.J., Hinder R.A., Klingler P., Gadenstatter M., Perdikis G., and Hinder P.R. Reflux esophagitis in humans is a free radical event. Dis Esophagus 10 (1997) 29-33
20. Olyaee M., Sontag S., Salman W., et al. Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut 37 (1995) 168-173
21. Theisen J., Peters J.H., Fein M., et al. The mutagenic potential of duodenoesophageal reflux. Ann Surg 241 (2005) 63-68
22. Lee J.S., Oh T.Y., Ahn B.O., et al. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res 480-481 (2001) 189-200
23. Fortini P., Pascucci B., Parlanti E., D'Errico M., Simonelli V., and Dogliotti E. 8-Oxoguanine DNA damage: at the crossroad of alternative repair pathways. Mutat Res 531 (2003) 127-139
24. Elahi A., Zheng Z., Park J., Eyring K., McCaffrey T., and Lazarus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 23 (2002) 1229-1234
25. Kim J.I., Park Y.J., Kim K.H., et al. hOGG1 Ser326Cys polymorphism modifies the significance of the environmental risk factor for colon cancer. World J Gastroenterol 9 (2003) 956-960
26. Takezaki T., Gao C.M., Wu J.Z., et al. hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int J Cancer 99 (2002) 624-627
27. Trzeciak A.R., Nyaga S.G., Jaruga P., Lohani A., Dizdaroglu M., and Evans M.K. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis 25 (2004) 1359-1370
28. Russo M.T., De Luca G., Degan P., et al. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res 64 (2004) 4411-4414
29. Rozalski R., Gackowski D., Roszkowski K., Foksinski M., and Olinski R. The level of 8-hydroxyguanine, a possible repair product of oxidative DNA damage, is higher in urine of cancer patients than in control subjects. Cancer Epidemiol Biomarkers Prev 11 (2002) 1072-1075
30. Manic S., Gatti L., Carenini N., Fumagalli G., Zunino F., and Perego P. Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair. Curr Cancer Drug Targets 3 (2003) 21-29